Brain damage and maternal medication

dc.contributor.authorO'Callaghan, M.
dc.contributor.authorMacLennan, A.
dc.date.issued2013
dc.description.statementofresponsibilityMichael E. O’Callaghan, Alastair H. MacLennan
dc.identifier.citationAmerican Journal of Obstetrics and Gynecology, 2013; 208(2):160-161
dc.identifier.doi10.1016/j.ajog.2012.11.022
dc.identifier.issn0002-9378
dc.identifier.issn1097-6868
dc.identifier.orcidO'Callaghan, M. [0000-0001-5038-5859] [0000-0002-8178-9714]
dc.identifier.urihttp://hdl.handle.net/2440/78690
dc.language.isoen
dc.publisherMosby Inc
dc.rights© 2013 Mosby, Inc. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.ajog.2012.11.022
dc.subjectHumans
dc.subjectBrain Injury, Chronic
dc.subjectCerebral Palsy
dc.subjectPregnancy Complications
dc.subjectPrenatal Exposure Delayed Effects
dc.subjectInfant, Premature, Diseases
dc.subjectPregnancy
dc.subjectFemale
dc.titleBrain damage and maternal medication
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_78690.pdf
Size:
126.25 KB
Format:
Adobe Portable Document Format
Description:
Accepted version